The FDA on Friday approved a subcutaneous (SC) induction regimen for risankizumab-rzaa (Skyrizi; AbbVie) in adults with moderately to severely active Crohn disease, giving patients the option to begin ...
Nevena Vicic, MSc, discusses first real-world data showing mRNA-1283 protected adults 65 and older from COVID-19 hospitalization in 2025-2026.
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
OneOncology's Larry Bilbrey outlines network-level contracting, data security, physician review of AI output, and clear ...
Nevena Vicic, MSc, discusses first real-world data showing mRNA-1283 protected adults 65 and older from COVID-19 ...
Two new approvals reshape the complicated UTI landscape within a single year: an intravenous option revived after ...
Recognizing Typical Lesions, Locations, and Chronicity" takes up the question of how clinicians can recognize HS reliably. Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results